Login
Home / 3349.T : JPX
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

COSMOS Pharmaceutical Corporation

¥6608 -$1125.00 (-14.55%)
JPX · 15 Sep 2026 06:30 UTC
Previous Close
¥6698
Day Range
¥6530¥6770
Year Range
¥5615¥9086
Market Cap
523.73B
AVG Volume
408.63K
Trailing/Forward PE
16.34/16.37
PEG ratio
2.51
Dividend Yield
1.24%
Next Earnings Date
2026-10-13
Primary Exchange
Tokyo Stock ExchangeJP
Revenue (JPY)
0100B200B300B24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Net Income (JPY)
02.5B5B7.5B10B24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Operating Income (JPY)
05B10B15B24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
EBITDA (JPY)
05B10B15B20B24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Cash Flows (JPY)
-15B-10B-5B024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
EPS (JPY)
05010015024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Expenses (JPY)
050B100B150BSG&ACapex24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Cash & Debt (JPY)
020B40B60B80BCashLong Term DebtShort Term Debt24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Debt ratios
-0.6-0.4-0.2-00.20.424 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Margins
0%10%20%30%24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Return on Capital
0%1%2%3%4%24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Shares Outstanding
020M40M60M80M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Dividends (JPY)
0204060Nov 22May 23Nov 23May 24Nov 24May 25Nov 25May 26Nov 26May 27
Book Value Per Share (JPY)
0100020003000400024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
Total Assets (JPY)
0200B400B600B24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PE Ratio
1015202530med 20.37Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-3%-2%-1%0%med 0%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.40.50.60.70.8med 0.58Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
68101214med 9.4Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
8.68.899.29.4med 9.03Sep 26Sep 26Sep 26
Price to Book
1.522.533.5med 2.3Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
COSMOS Pharmaceutical Corporation
3349.T
Stockpicker

Video analysis: 3349.T

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.